Agglomeration of titanium dioxide nanoparticles increases toxicological responses in vitro and in vivo.


Journal

Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354

Informations de publication

Date de publication:
26 02 2020
Historique:
received: 23 09 2019
accepted: 06 02 2020
entrez: 27 2 2020
pubmed: 27 2 2020
medline: 15 12 2020
Statut: epublish

Résumé

The terms agglomerates and aggregates are frequently used in the regulatory definition(s) of nanomaterials (NMs) and hence attract attention in view of their potential influence on health effects. However, the influence of nanoparticle (NP) agglomeration and aggregation on toxicity is poorly understood although it is strongly believed that smaller the size of the NPs greater the toxicity. A toxicologically relevant definition of NMs is therefore not yet available, which affects not only the risk assessment process but also hinders the regulation of nano-products. In this study, we assessed the influence of NP agglomeration on their toxicity/biological responses in vitro and in vivo. We tested two TiO Agglomeration of TiO

Sections du résumé

BACKGROUND
The terms agglomerates and aggregates are frequently used in the regulatory definition(s) of nanomaterials (NMs) and hence attract attention in view of their potential influence on health effects. However, the influence of nanoparticle (NP) agglomeration and aggregation on toxicity is poorly understood although it is strongly believed that smaller the size of the NPs greater the toxicity. A toxicologically relevant definition of NMs is therefore not yet available, which affects not only the risk assessment process but also hinders the regulation of nano-products. In this study, we assessed the influence of NP agglomeration on their toxicity/biological responses in vitro and in vivo.
RESULTS
We tested two TiO
CONCLUSION
Agglomeration of TiO

Identifiants

pubmed: 32101144
doi: 10.1186/s12989-020-00341-7
pii: 10.1186/s12989-020-00341-7
pmc: PMC7045370
doi:

Substances chimiques

titanium dioxide 15FIX9V2JP
Titanium D1JT611TNE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10

Références

Biomaterials. 2010 May;31(13):3657-66
pubmed: 20138662
Toxicol Lett. 2012 Oct 17;214(2):109-19
pubmed: 22944471
Nanotoxicology. 2015;9(7):871-85
pubmed: 25672815
IARC Monogr Eval Carcinog Risks Hum. 2010;93:1-413
pubmed: 21449489
J Hazard Mater. 2017 Aug 5;335:125-134
pubmed: 28437696
Part Fibre Toxicol. 2014 Feb 17;11:11
pubmed: 24529161
Part Fibre Toxicol. 2014 Mar 25;11:13
pubmed: 24666995
Arch Toxicol. 2016 Dec;90(12):2885-2916
pubmed: 27699444
Environ Toxicol Chem. 2012 Aug;31(8):1679-92
pubmed: 22573562
Nanotoxicology. 2013 May;7(3):274-93
pubmed: 22264143
Part Fibre Toxicol. 2014 May 01;11:20
pubmed: 24885440
Environ Sci Technol. 2012 Feb 21;46(4):2242-50
pubmed: 22260395
Nanotoxicology. 2017 Feb;11(1):7-19
pubmed: 27894206
Nanoscale Res Lett. 2013 Nov 21;8(1):496
pubmed: 24261419
Ann Occup Hyg. 2016 Oct;60(8):916-35
pubmed: 27422281
Environ Sci Technol. 2013 Jan 15;47(2):1057-64
pubmed: 23240597
Nanomedicine (Lond). 2015 Oct;10(19):3015-3032
pubmed: 26419834
ACS Nano. 2013 Mar 26;7(3):1929-42
pubmed: 23387956
Environ Health Perspect. 2002 Aug;110(8):797-800
pubmed: 12153761
Part Fibre Toxicol. 2011 Jul 27;8:22
pubmed: 21794132
Toxicol In Vitro. 2016 Jun;33:125-35
pubmed: 26928046
Beilstein J Nanotechnol. 2015 Aug 21;6:1769-80
pubmed: 26425429
Arch Toxicol. 2015 May;89(5):659-75
pubmed: 25618546
Toxicol Lett. 2012 Feb 5;208(3):197-213
pubmed: 22108609
J Environ Monit. 2012 Feb;14(2):455-64
pubmed: 22277962
J Nanobiotechnology. 2012 Jun 18;10:24
pubmed: 22709926
Environ Sci Technol. 2010 Oct 1;44(19):7309-14
pubmed: 20536146
Nat Protoc. 2017 Feb;12(2):355-371
pubmed: 28102836
Mutagenesis. 2017 Jan;32(1):181-191
pubmed: 28011750
Mutagenesis. 2017 Jan;32(1):139-149
pubmed: 27789654
Regul Toxicol Pharmacol. 2015 Oct;73(1):137-50
pubmed: 26111608
Environ Int. 2015 Apr;77:132-47
pubmed: 25705000
Part Fibre Toxicol. 2013 Oct 04;10:48
pubmed: 24090040
Nanoscale Res Lett. 2011 Dec;6(1):27
pubmed: 27502650
Small. 2009 Apr;5(7):846-53
pubmed: 19288475
Part Fibre Toxicol. 2013 Apr 15;10:15
pubmed: 23587290
Mutat Res. 2017 Feb;796:1-12
pubmed: 28212500
Regul Toxicol Pharmacol. 2013 Feb;65(1):119-25
pubmed: 23200793
Arch Toxicol. 2017 Jan;91(1):353-363
pubmed: 26872950
Toxicol Sci. 2006 Jul;92(1):174-85
pubmed: 16613837
ACS Nano. 2011 Jul 26;5(7):5478-89
pubmed: 21692495
J Food Drug Anal. 2014 Mar;22(1):95-104
pubmed: 24673907

Auteurs

Sivakumar Murugadoss (S)

Laboratory of Toxicology, Unit of Environment and Health, Department of Public Health and Primary Care, KU Leuven, 3000, Leuven, Belgium.

Frederic Brassinne (F)

Trace Elements and Nanomaterials, Sciensano, 1180, Uccle, Belgium.

Noham Sebaihi (N)

National Standards, FPS Economy, 1000, Brussels, Belgium.

Jasmine Petry (J)

National Standards, FPS Economy, 1000, Brussels, Belgium.

Stevan M Cokic (SM)

Department of Oral Health Sciences, KU Leuven, BIOMAT & UZ Leuven (University Hospitals Leuven), Dentistry, Kapucijnenvoer 7, 3000, Leuven, Belgium.

Kirsten L Van Landuyt (KL)

Department of Oral Health Sciences, KU Leuven, BIOMAT & UZ Leuven (University Hospitals Leuven), Dentistry, Kapucijnenvoer 7, 3000, Leuven, Belgium.

Lode Godderis (L)

Laboratory for Occupational and Environmental Hygiene, Unit of Environment and Health, Department of Public Health and Primary Care, KU Leuven, 3000, Leuven, Belgium.
IDEWE, External Service for Prevention and Protection at work, Interleuvenlaan 58, 3001, Heverlee, Belgium.

Jan Mast (J)

Trace Elements and Nanomaterials, Sciensano, 1180, Uccle, Belgium.

Dominique Lison (D)

Louvain centre for Toxicology and Applied Pharmacology, Institute of Experimental and Clinical Research, Université catholique de Louvain, 1200, Brussels, Belgium.

Peter H Hoet (PH)

Laboratory of Toxicology, Unit of Environment and Health, Department of Public Health and Primary Care, KU Leuven, 3000, Leuven, Belgium. peter.hoet@kuleuven.be.

Sybille van den Brule (S)

Louvain centre for Toxicology and Applied Pharmacology, Institute of Experimental and Clinical Research, Université catholique de Louvain, 1200, Brussels, Belgium. sybille.vandenbrule@uclouvain.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH